- Home
- ADVB vs CPIX Comparison
ADVB vs CPIX Comparison
Compare ADVB & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVB
- CPIX
- Stock Information
- Founded
- ADVB 2014
- CPIX 1999
- Country
- ADVB United States
- CPIX United States
- Employees
- ADVB N/A
- CPIX N/A
- Industry
- ADVB Medical Specialities
- CPIX Biotechnology: Pharmaceutical Preparations
- Sector
- ADVB Health Care
- CPIX Health Care
- Exchange
- ADVB Nasdaq
- CPIX Nasdaq
- Market Cap
- ADVB 79.0M
- CPIX 68.7M
- IPO Year
- ADVB 2025
- CPIX 2009
- Fundamental
- Price
- ADVB $3.83
- CPIX $4.36
- Analyst Decision
- ADVB
- CPIX
- Analyst Count
- ADVB 0
- CPIX 0
- Target Price
- ADVB N/A
- CPIX N/A
- AVG Volume (30 Days)
- ADVB 113.8K
- CPIX 112.7K
- Earning Date
- ADVB 01-01-0001
- CPIX 03-04-2025
- Dividend Yield
- ADVB N/A
- CPIX N/A
- EPS Growth
- ADVB N/A
- CPIX N/A
- EPS
- ADVB N/A
- CPIX N/A
- Revenue
- ADVB N/A
- CPIX $37,867,945.00
- Revenue This Year
- ADVB N/A
- CPIX N/A
- Revenue Next Year
- ADVB N/A
- CPIX N/A
- P/E Ratio
- ADVB N/A
- CPIX N/A
- Revenue Growth
- ADVB N/A
- CPIX N/A
- 52 Week Low
- ADVB $3.06
- CPIX $1.04
- 52 Week High
- ADVB $4.10
- CPIX $7.25
- Technical
- Relative Strength Index (RSI)
- ADVB N/A
- CPIX 44.29
- Support Level
- ADVB N/A
- CPIX $3.91
- Resistance Level
- ADVB N/A
- CPIX $4.47
- Average True Range (ATR)
- ADVB 0.00
- CPIX 0.34
- MACD
- ADVB 0.00
- CPIX -0.15
- Stochastic Oscillator
- ADVB 0.00
- CPIX 26.63
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.